Archives

Pharmaceutical groups have raised concerns that FDA’s draft social media guidance are not practical and could discourage pharmaceutical companies from interacting with consumers via social [...]

The FDA often sends warning letters to companies for violating FDA regulation on how their products are marketed. For instance, if a company is advertising its product as a treatment for an [...]